Jazz Pharmaceuticals to Participate in the 2025 Wells Fargo Healthcare Conference
DUBLIN, Aug. 21, 2025 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the 2025 Wells Fargo Healthcare Conference. Company management will participate in a fireside chat on Wednesday, September 3, 2025, at 6:30 a.m. PDT / 9:30 p.m. EDT / 2:30 p.m. IST. An audio webcast of the […]
OppFi Publishes Supplemental Information Regarding its Warrants
CHICAGO, Aug. 21, 2025 /PRNewswire/ — OppFi Inc. (NYSE: OPFI) (“OppFi” or the “Company”), a tech-enabled digital finance platform that partners with banks to offer financial products and services to everyday Americans, announced today that it has published supplemental information regarding its outstanding warrants to purchase shares of the Company’s Class A common stock. “As OppFi […]
QuidelOrtho Completes Debt Refinancing
SAN DIEGO, Aug. 21, 2025 /PRNewswire/ — QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced the completion of a series of related transactions to refinance its debt structure and support future growth. Through these transactions, the […]
INVESTOR DEADLINE AUGUST 25: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – SRPT
SAN DIEGO, Aug. 21, 2025 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) securities between June 22, 2023 and June 24, 2025, inclusive (the “Class Period”), have until Monday, August 25, 2025 to seek appointment as lead plaintiff of the […]
Honeywell Announces Filing of Form 10 Registration Statement and Upcoming Investor Day for Planned Spin-Off of Solstice Advanced Materials
Solstice Advanced Materials will be a pure-play specialty materials company with leading market positions in refrigerants, semiconductor materials, protective fibers, and healthcare packaging solutions Filing marks latest milestone as Solstice prepares to become a standalone public company in the fourth quarter of 2025 Investor Day scheduled for October 8, 2025, in New York City to […]
Honeywell Unveils Strategic Board of Directors to Lead Solstice Advanced Materials
Board Comprises Senior Leaders with Innovation, Technology, and Industrial Sector Expertise Spin-Off On Track for Completion in the Fourth Quarter of 2025 CHARLOTTE, N.C., Aug. 21, 2025 /PRNewswire/ — Honeywell (NASDAQ: HON) today announced the future Board of Directors for Solstice Advanced Materials (“Solstice”), a pure-play specialty materials company that will be created following its planned […]
VERMONT TEAMSTERS LOCKED OUT AT TRAVEL KUZ ONE WEEK BEFORE SCHOOL STARTS
Thousands of Students Could Be Left Without Transportation BRATTLEBORO, Vt., Aug. 21, 2025 /PRNewswire/ — Teamsters school bus drivers and monitors are locked out at Travel Kuz, a subsidiary of Beacon Mobility, as the company refuses to bargain in good faith. The workers provide student transportation for Windham SE Supervisory Union. Since the last round of negotiations […]
White Castle announces plans to bring its first restaurant to Texas
The new Castle in The Colony is scheduled to open in 2026 COLUMBUS, Ohio, Aug. 21, 2025 /PRNewswire/ — White Castle, America’s fast-food pioneer and the company behind The Original Slider®, made a monumental announcement. For the first time in its 104 years, the family-owned business is opening a restaurant in Texas! Continue Reading White Castle’s […]
Vanda Seeks FDA Commissioner Review of Outgoing CDER Director’s Decision to Uphold Approval of Two Generic Versions of Hetlioz®
WASHINGTON, Aug. 21, 2025 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it has asked Martin Makary, the Commissioner of the U.S. Food and Drug Administration (FDA) to review the decision made by Jacqueline Corrigan-Curay, the departing director of the FDA’s Center for Drug Evaluation and Research (CDER), days before her retirement […]
Lineage, Inc. (LINE) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
BENSALEM, Pa., Aug. 21, 2025 /PRNewswire/ — The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN LINEAGE, INC. (LINE), CONTACT THE LAW OFFICES […]